Qnovia is a biotechnology company that specializes in developing innovative drug delivery systems, focusing particularly on inhalation-based technologies. The company aims to enhance the delivery of a wide range of pharmaceuticals, including nicotine, by creating advanced aerosol devices and formulations that address the limitations of traditional drug delivery methods. Qnovia's platform not only seeks to improve patient outcomes through more effective inhaled therapies but also emphasizes responsible sourcing and transparency in product information. By prioritizing innovation and patient-centric solutions, Qnovia strives to contribute positively to public health and the overall experience of medication delivery.
AvantGuard
Seed Round in 2023
AvantGuard creats innovative solutions that manage surfaces and provide long-term protection against viruses, bacteria, and fungi/mold, in a variety of applications.
Qnovia is a biotechnology company that specializes in developing innovative drug delivery systems, focusing particularly on inhalation-based technologies. The company aims to enhance the delivery of a wide range of pharmaceuticals, including nicotine, by creating advanced aerosol devices and formulations that address the limitations of traditional drug delivery methods. Qnovia's platform not only seeks to improve patient outcomes through more effective inhaled therapies but also emphasizes responsible sourcing and transparency in product information. By prioritizing innovation and patient-centric solutions, Qnovia strives to contribute positively to public health and the overall experience of medication delivery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.